Drugs / Xiang-Sha-Liu-Jun-Zi-Tang
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT02179580 | Jun 2014 → Dec 2015 | irritable bowel syndrome | China Medical University Hospital | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT04388358 | Sep → Oct 2019 | allergic rhinitis | Chang Gung Memorial Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xiang-sha-liu-jun-zi-tang | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04388358 ↗ |
| Known as | XSLJZT | “A Randomized Double Blind Placebo Control Study of Xiang-Sha-Liu-Jun-Zi-Tang (XSLJZT)in Patients With Irritable Bowel Syndrome” NCT02179580 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “We use the Chinese herb for the treat of IBS patient” NCT02179580 ↗ |